The Journal of Asthma, published by Taylor & Francis Ltd, stands as a prominent platform for disseminating crucial research in the fields of respiratory health, particularly focusing on asthma and related conditions. With an impact factor reflecting its esteemed position—ranking in the second and third quartiles of categories such as Immunology and Allergy, Medicine (miscellaneous), Pediatrics, and Pulmonary and Respiratory Medicine—the journal provides comprehensive insights into the latest findings and advancements in clinical practice and research. The journal, which has been in circulation since 1963, embraces a multidisciplinary approach, catering to a diverse audience that includes researchers, healthcare professionals, and students. Although it does not offer open access, it remains a critical resource for those seeking to deepen their understanding of asthma pathology and treatment strategies. The Journal of Asthma continues to serve as a vital academic forum, advancing knowledge and prompting innovation in the management of this pervasive health issue.

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

Journal of Aggression Maltreatment & Trauma is a premier scholarly publication dedicated to the exploration of the multifaceted nature of aggression, maltreatment, and trauma across diverse populations and settings. Published by Routledge Journals, a renowned division of Taylor & Francis Ltd, this journal serves as a vital resource for researchers, mental health professionals, and academicians committed to advancing evidence-based practices and knowledge in the fields of clinical psychology, psychiatry, and health professions. With an impressive impact factor that places it in the Q1 category for Health Professions (miscellaneous) and Q2 for Clinical Psychology and Psychiatry and Mental Health as of 2023, the journal fosters high-quality research and debate. The varied themes encompass empirical studies, theoretical discussions, and practical applications, making it a cornerstone for disseminating cutting-edge research from 1997 to the present. Although this journal is not open access, its extensive reach and reputation ensure that it continues to be a premier destination for impactful scholarship, facilitating dialogue among peers and promoting understanding in the critical areas of aggression and trauma.

Journal of Psychosomatic Obstetrics & Gynecology, published by TAYLOR & FRANCIS LTD, is a leading open access academic journal that has been instrumental in bridging the gaps between psychosomatic health, obstetrics, and gynecology since its inception in 1982. With a commitment to disseminating high-quality research across a broad spectrum of interrelated fields, this journal is categorized in the Q2 quartile for Clinical Psychology, Obstetrics and Gynecology, Psychiatry and Mental Health, and Reproductive Medicine. The journal boasts impressive Scopus rankings, positioning it prominently at the 83rd percentile for Obstetrics and Gynecology and the 81st percentile for Clinical Psychology. This vital resource serves as a platform for researchers, clinicians, and students alike, fostering innovative discussions and advancements in understanding the psychosomatic dimensions of women’s health. With the transition to open access in 2023, the journal further enhances its reach and accessibility, ensuring that critical research findings are available worldwide, promoting informed practices and improving patient care.

AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.

Surgery for Obesity and Related Diseases is an esteemed scholarly journal published by ELSEVIER SCIENCE INC, focusing on cutting-edge research and advancements in the field of obesity surgery. With an impressive impact factor and ranking in the 94th percentile among its peers in Medicine and Surgery, this journal maintains a prestigious position in the Q1 category of surgical studies. Since its inception in 2005, it has served as a vital platform for disseminating original research, clinical studies, and reviews that aim to improve patient outcomes and deepen our understanding of obesity-related diseases. The journal facilitates a wide array of access options, ensuring that professionals, researchers, and students across the globe can engage with current findings and best practices in surgical and medical treatment of obesity. As we look toward 2024 and beyond, Surgery for Obesity and Related Diseases remains committed to fostering innovation in surgical techniques and interdisciplinary approaches to solving one of the most pressing health challenges of our time.

EUROPEAN PSYCHIATRY, published by Cambridge University Press, stands at the forefront of advancements in the field of psychiatry and mental health, serving as a vital resource for researchers, professionals, and students alike. With an impressive Q1 ranking in Psychiatry and Mental Health and an impact factor that underscores its significance, this journal fosters innovative studies and discussions that shape contemporary understanding of mental health issues. Offering Open Access since 2020, it ensures that high-quality research is readily available to a global audience, bridging gaps in knowledge dissemination. The journal, which has been publishing since 1991, encompasses a broad range of topics relevant to mental health, emphasizing evidence-based practices and interdisciplinary approaches to treatment and care. With its ongoing commitment to excellence, EUROPEAN PSYCHIATRY continues to be an indispensable platform for advancing the science of mental health.

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.